Surmodics to Present at Upcoming Investor Conferences
March 15 2018 - 8:30AM
Business Wire
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical
device and in vitro diagnostic technologies to the healthcare
industry, today announced that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
information systems and chief financial officer, will be attending
two upcoming investor conferences in New York City.
On Tuesday, March 20, at 1:35 p.m. ET (12:35 p.m. CT),
company management will make a presentation at the Oppenheimer 28th
Annual Healthcare Conference.
On Tuesday, March 27, at 2:30 p.m. ET (1:30 p.m. CT),
company management will make a presentation at the Needham
Healthcare Conference.
Live audio webcasts of the presentations can be accessed by
going to the investor relations portion of the Company’s website at
www.surmodics.com and clicking on the webcast icon. Webcasts will
be archived on the Company’s website for 90 days.
About Surmodics, Inc.Surmodics is the global leader
in surface modification technologies for intravascular medical
devices and a leading provider of chemical components for
in vitro diagnostic (IVD) immunoassay tests and
microarrays. Surmodics is pursuing highly differentiated
whole-product solutions that are designed to address unmet clinical
needs for its medical device customers and engineered to the most
demanding requirements. This key growth strategy
leverages the combination of the Company’s expertise
in proprietary surface technologies, along with enhanced
device design, development and manufacturing capabilities. The
Company mission remains to improve the detection and
treatment of disease. Surmodics is headquartered in Eden
Prairie, Minnesota. For more information, visit
www.surmodics.com. The content of Surmodics’ website is not
part of this press release or part of any filings that
the company makes with the SEC.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180315005284/en/
Surmodics, Inc.Andy LaFrence,
952-500-7000ir@surmodics.com
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
SurModics (NASDAQ:SRDX)
Historical Stock Chart
From Apr 2023 to Apr 2024